Thermo Fisher CDR (Cad Hedged) (TMO.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,273,000 | 2,288,000 | 1,106,000 | 2,103,000 | 1,098,000 |
| Receivables | 4,384,000 | 4,129,000 | 4,155,000 | 4,136,000 | 4,257,000 |
| Inventories | 3,308,000 | 3,209,000 | 3,124,000 | 3,005,000 | 2,982,000 |
| Other current assets | 1,549,000 | 1,597,000 | 1,554,000 | 1,381,000 | 1,229,000 |
| TOTAL | $10,514,000 | $11,223,000 | $9,939,000 | $10,625,000 | $9,566,000 |
| Non-Current Assets | |||||
| PPE Net | 4,420,000 | 4,394,000 | 4,192,000 | 4,165,000 | 3,978,000 |
| Intangibles | 39,935,000 | 40,620,000 | 39,725,000 | 40,325,000 | 40,361,000 |
| Other Non-Current Assets | 1,860,000 | 1,733,000 | 1,740,000 | 1,117,000 | 1,173,000 |
| TOTAL | $46,215,000 | $46,747,000 | $45,657,000 | $45,607,000 | $45,512,000 |
| Total Assets | $56,729,000 | $57,970,000 | $55,596,000 | $56,232,000 | $55,078,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 661,000 | 2,377,000 | 1,336,000 | 1,271,000 | 1,014,000 |
| Accounts payable and accrued liabilities | 1,659,000 | 1,391,000 | 1,462,000 | 1,615,000 | 1,344,000 |
| Accrued Expenses | 2,581,000 | 2,679,000 | 2,133,000 | 2,452,000 | 2,041,000 |
| TOTAL | $5,844,000 | $7,509,000 | $5,898,000 | $6,147,000 | $5,196,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 16,392,000 | 16,663,000 | 16,812,000 | 17,719,000 | 17,760,000 |
| Deferred Revenues | 943,000 | 1,062,000 | 967,000 | 809,000 | 797,000 |
| Other Non-Current Liabilities | 3,137,000 | 3,133,000 | 3,048,000 | 2,515,000 | 2,682,000 |
| TOTAL | $21,530,000 | $21,732,000 | $22,005,000 | $22,499,000 | $22,992,000 |
| Total Liabilities | $27,374,000 | $29,241,000 | $27,903,000 | $28,646,000 | $28,188,000 |
| Shareholders' Equity | |||||
| Common Shares | 434,000 | 433,000 | 433,000 | 432,000 | 431,000 |
| Retained earnings | 21,165,000 | 20,482,000 | 19,439,000 | 18,696,000 | 17,866,000 |
| Other shareholders' equity | -2,722,000 | -2,630,000 | -2,509,000 | -2,498,000 | -2,519,000 |
| TOTAL | $29,355,000 | $28,729,000 | $27,693,000 | $27,586,000 | $26,890,000 |
| Total Liabilities And Equity | $56,729,000 | $57,970,000 | $55,596,000 | $56,232,000 | $55,078,000 |